SentiAR
St. Louis, US · Founded 2017 · Delaware corporation · 3 known investors
SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures. Sold to hospitals and ambulatory surgery centers, it aims to replace boom-mounted display systems and improve navigation accuracy in the EP lab.</parameter> <parameter name="hq_city">St. Louis
Founders & leadership
SentiAR was founded in 2017 by Jonathan Silva.

Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$16.7M disclosed across 6 rounds · 2017–2026
▶$1.5MraisedMay 2026 · 9 investors · Other Health CareRule 506(b)
- Churchill SeanDirector
- Stuart LongExecutive Officer, Director
- Jon SilvaDirector
- Offering amount
- $2.5M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMay 2025 · 20 investors · Other Health CareRule 506(b)
- Sean ChurchillDirector
- Warren WatsonDirector
- Jonathan SilvaExecutive Officer, Director
- Berk TasExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedMar 2023 · 15 investors · Other Health CareRule 506(b)
- Sean ChurchillDirector
- Jen SilvaDirector
- Warren WatsonDirector
- Berk TasExecutive Officer, Director
- Shlomo ShpunDirector
- Offering amount
- $5.8M
- Amount sold
- $5.8M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedNov 2020 · 15 investors · Other Health CareRule 506(b)
- Charlie BoltenDirector
- Jon SilvaDirector
- Berk TasExecutive Officer, Director
- William SchmidtDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- Minimum investment
- $5K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1MraisedApr 2018 · 4 investors · Other Health CareRule 506(b)
- William SchmidtDirector
- Jennifer SilvaDirector
- Charles BoltenDirector
- Jonathan SilvaDirector
- James Patrick HowardExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1M
- Minimum investment
- $50K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$300KraisedAug 2017 · 4 investors · Other Health CareRule 506(b)
- James Patrick HowardExecutive Officer
- Offering amount
- $1M
- Amount sold
- $300K
- Minimum investment
- $50K
- Proceeds to insiders
- $140K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with SentiAR for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SentiAR do?
- SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures. Sold to hospitals and ambulatory surgery centers, it aims to replace boom-mounted display systems and improve navigation accuracy in the EP lab.</parameter> <parameter name="hq_city">St. Louis
- Who founded SentiAR?
- SentiAR was founded by Jonathan Silva in 2017.
- Who are SentiAR's investors?
- SentiAR's investors include Missouri Technology Corporation, BioGenerator Ventures, Cultivation Capital.
- How much funding has SentiAR raised?
- SentiAR has disclosed $16.7M raised across 6 rounds.
- Where is SentiAR headquartered?
- SentiAR is headquartered in St. Louis, US.

